BIOREGENX, INC. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f4f507ae-a30a-43d8-9cab-cad13cd6ba01/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.9M | 2025-01-01 – 2025-12-31 | evidence 0001683168-26-002975 |
| FY 2024 | $2.3M | 2024-01-01 – 2024-12-31 | evidence 0001683168-25-002614 |
| FY 2023 | $3.4M | 2023-01-01 – 2023-12-31 | evidence 0001683168-25-002614 |
| FY 2022 | $42.2k | 2022-01-01 – 2022-12-31 | evidence 0001683168-23-002125 |
| FY 2021 | $198.6k | 2021-01-01 – 2021-12-31 | evidence 0001683168-23-002125 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).